To view this email as a web page, click here.
 
HIGHLIGHTS   |  June 21, 2019
 
Timing of Colorectal Cancer Screening: How Current Guidelines Vary
This slideshow reviews the latest guidelines and updates on colorectal cancer screening.
Read more
 
ADVERTISEMENT
FDA Approves Polatuzumab Vedotin-Piiq Combination for DLBCL Patients
The FDA granted accelerated approval to polatuzumab vedotin-piiq in combination with bendamustine and a rituximab product for adults with relapsed or refractory diffuse large B-cell lymphoma.
Read more
 
IN CASE YOU MISSED IT
 
Using Radiation Therapy to Reduce Recurrence in DCIS
Cancer Network spoke with Dr. Carmen Bergom about advancements in the treatment of DCIS and the importance of using local recurrence patterns to help guide future research.
Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.